<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">28338050</PMID><DateCompleted><Year>2018</Year><Month>11</Month><Day>08</Day></DateCompleted><DateRevised><Year>2018</Year><Month>11</Month><Day>13</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2045-2322</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><PubDate><Year>2017</Year><Month>Mar</Month><Day>24</Day></PubDate></JournalIssue><Title>Scientific reports</Title><ISOAbbreviation>Sci Rep</ISOAbbreviation></Journal><ArticleTitle>Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway.</ArticleTitle><Pagination><StartPage>45171</StartPage><MedlinePgn>45171</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">45171</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/srep45171</ELocationID><Abstract><AbstractText>Dengue virus (DENV) infects 400 million people worldwide annually. Infection of more than one serotype of DENV highly corresponds to dengue hemorrhagic fever and dengue shock syndrome, which are the leading causes of high mortality. Due to lack of effective vaccines and unavailable therapies against DENV, discovery of anti-DENV agents is urgently needed. We first characterize that Schisandrin A can inhibit the replication of four serotypes of DENV in a concentration- and time-dependent manner, with an effective half-maximal effective concentration 50% (EC<sub>50</sub>) value of 28.1&#x2009;&#xb1;&#x2009;0.42&#x2009;&#x3bc;M against DENV serotype type 2 without significant cytotoxicity. Furthermore, schisandrin A can effectively protect mice from DENV infection by reducing disease symptoms and mortality of DENV-infected mice. We demonstrate that STAT1/2-mediated antiviral interferon responses contribute to the action of schisandrin A against DENV replication. Schisandrin A represents a potential antiviral agent to block DENV replication in vitro and in vivo. In conclusion, stimulation of STAT1/2-mediated antiviral interferon responses is a promising strategy to develop antiviral drug.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yu</LastName><ForeName>Jung-Sheng</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>Department of Chinese Medicine, Chi Mei Medical Center, Tainan 71004, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Integrated Medicine, China Medical University, Taichung 40402, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yu-Hsuan</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tseng</LastName><ForeName>Chin-Kai</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center of Infectious Disease and Signaling Research, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Chun-Kuang</ForeName><Initials>CK</Initials><AffiliationInfo><Affiliation>Doctoral Degree Program in Marine Biotechnology, College of Marine Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Yao-Chin</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Department of Chinese Medicine, Chi Mei Medical Center, Tainan 71004, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yen-Hsu</ForeName><Initials>YH</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Department of Internal Medicine, Kaohsiung Medical University, Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Dengue Fever Control and Research, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jin-Ching</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Biotechnology, College of Life Science, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Natural Products, College of Pharmacy, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Center for Natural Products and Drug Development, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2017</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Sci Rep</MedlineTA><NlmUniqueID>101563288</NlmUniqueID><ISSNLinking>2045-2322</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034242">Cyclooctanes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017705">Lignans</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D011083">Polycyclic Compounds</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D050791">STAT Transcription Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>74XQL5DO3S</RegistryNumber><NameOfSubstance UI="C034734">schizandrin A</NameOfSubstance></Chemical><Chemical><RegistryNumber>9008-11-1</RegistryNumber><NameOfSubstance UI="D007372">Interferons</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045744" MajorTopicYN="N">Cell Line, Tumor</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006224" MajorTopicYN="N">Cricetinae</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003412" MajorTopicYN="N">Cricetulus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034242" MajorTopicYN="N">Cyclooctanes</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003715" MajorTopicYN="N">Dengue</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007372" MajorTopicYN="N">Interferons</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017705" MajorTopicYN="N">Lignans</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008813" MajorTopicYN="N">Mice, Inbred ICR</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011083" MajorTopicYN="N">Polycyclic Compounds</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D050791" MajorTopicYN="N">STAT Transcription Factors</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2016</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2017</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2017</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2017</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2018</Year><Month>11</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">28338050</ArticleId><ArticleId IdType="pmc">PMC5364541</ArticleId><ArticleId IdType="doi">10.1038/srep45171</ArticleId><ArticleId IdType="pii">srep45171</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ng J. K. et al.. First experimental in vivo model of enhanced dengue disease severity through maternally acquired heterotypic dengue antibodies. PLoS pathogens 10, e1004031, doi: 10.1371/journal.ppat.1004031 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1004031</ArticleId><ArticleId IdType="pmc">PMC3974839</ArticleId><ArticleId IdType="pubmed">24699622</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J. C. et al.. Characterization of the activity of 2&#x2032;-C-methylcytidine against dengue virus replication. Antiviral research 116, 1&#x2013;9, doi: 10.1016/j.antiviral.2015.01.002 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2015.01.002</ArticleId><ArticleId IdType="pubmed">25614455</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice C. M. et al.. Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution. Science 229, 726&#x2013;733 (1985).</Citation><ArticleIdList><ArticleId IdType="pubmed">4023707</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee Y. R. et al.. Dengue virus infection induces autophagy: an in vivo study. Journal of biomedical science 20, 65, doi: 10.1186/1423-0127-20-65 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1423-0127-20-65</ArticleId><ArticleId IdType="pmc">PMC3848819</ArticleId><ArticleId IdType="pubmed">24011333</ArticleId></ArticleIdList></Reference><Reference><Citation>Dalrymple N. A., Cimica V. &amp; Mackow E. R. Dengue Virus NS Proteins Inhibit RIG-I/MAVS Signaling by Blocking TBK1/IRF3 Phosphorylation: Dengue Virus Serotype 1 NS4A Is a Unique Interferon-Regulating Virulence Determinant. mBio 6, e00553&#x2013;00515, doi: 10.1128/mBio.00553-15 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00553-15</ArticleId><ArticleId IdType="pmc">PMC4436066</ArticleId><ArticleId IdType="pubmed">25968648</ArticleId></ArticleIdList></Reference><Reference><Citation>Chareonsirisuthigul T., Kalayanarooj S. &amp; Ubol S. Dengue virus (DENV) antibody-dependent enhancement of infection upregulates the production of anti-inflammatory cytokines, but suppresses anti-DENV free radical and pro-inflammatory cytokine production, in THP-1 cells. The Journal of general virology 88, 365&#x2013;375, doi: 10.1099/vir.0.82537-0 (2007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.82537-0</ArticleId><ArticleId IdType="pubmed">17251552</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones M. et al.. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression. Journal of virology 79, 5414&#x2013;5420, doi: 10.1128/JVI.79.9.5414-5420.2005 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.9.5414-5420.2005</ArticleId><ArticleId IdType="pmc">PMC1082737</ArticleId><ArticleId IdType="pubmed">15827155</ArticleId></ArticleIdList></Reference><Reference><Citation>Ubol S. et al.. Differences in global gene expression in peripheral blood mononuclear cells indicate a significant role of the innate responses in progression of dengue fever but not dengue hemorrhagic fever. The Journal of infectious diseases 197, 1459&#x2013;1467, doi: 10.1086/587699 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/587699</ArticleId><ArticleId IdType="pubmed">18444802</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison J. et al.. Dengue virus co-opts UBR4 to degrade STAT2 and antagonize type I interferon signaling. PLoS pathogens 9, e1003265, doi: 10.1371/journal.ppat.1003265 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003265</ArticleId><ArticleId IdType="pmc">PMC3610674</ArticleId><ArticleId IdType="pubmed">23555265</ArticleId></ArticleIdList></Reference><Reference><Citation>Fink K. &amp; Grandvaux N. STAT2 and IRF9: Beyond ISGF3. Jak-Stat 2, e27521, doi: 10.4161/jkst.27521 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/jkst.27521</ArticleId><ArticleId IdType="pmc">PMC3906322</ArticleId><ArticleId IdType="pubmed">24498542</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang D. et al.. Identification of five interferon-induced cellular proteins that inhibit west nile virus and dengue virus infections. Journal of virology 84, 8332&#x2013;8341, doi: 10.1128/JVI.02199-09 (2010).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02199-09</ArticleId><ArticleId IdType="pmc">PMC2916517</ArticleId><ArticleId IdType="pubmed">20534863</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon-Loriere E. et al.. High Anti-Dengue Virus Activity of the OAS Gene Family Is Associated With Increased Severity of Dengue. The Journal of infectious diseases 212, 2011&#x2013;2020, doi: 10.1093/infdis/jiv321 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiv321</ArticleId><ArticleId IdType="pubmed">26063222</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C. Y. et al.. Dengue virus targets the adaptor protein MITA to subvert host innate immunity. PLoS pathogens 8, e1002780, doi: 10.1371/journal.ppat.1002780 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002780</ArticleId><ArticleId IdType="pmc">PMC3386177</ArticleId><ArticleId IdType="pubmed">22761576</ArticleId></ArticleIdList></Reference><Reference><Citation>Munoz-Jordan J. L. et al.. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. Journal of virology 79, 8004&#x2013;8013, doi: 10.1128/JVI.79.13.8004-8013.2005 (2005).</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.13.8004-8013.2005</ArticleId><ArticleId IdType="pmc">PMC1143737</ArticleId><ArticleId IdType="pubmed">15956546</ArticleId></ArticleIdList></Reference><Reference><Citation>Checker R. et al.. Schisandrin B exhibits anti-inflammatory activity through modulation of the redox-sensitive transcription factors Nrf2 and NF-kappaB. Free radical biology &amp; medicine 53, 1421&#x2013;1430, doi: 10.1016/j.freeradbiomed.2012.08.006 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2012.08.006</ArticleId><ArticleId IdType="pubmed">22917978</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H. et al.. Comprehensive chemical analysis of Schisandra chinensis by HPLC-DAD-MS combined with chemometrics. Phytomedicine: international journal of phytotherapy and phytopharmacology 20, 1135&#x2013;1143, doi: 10.1016/j.phymed.2013.05.001 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phymed.2013.05.001</ArticleId><ArticleId IdType="pubmed">23880331</ArticleId></ArticleIdList></Reference><Reference><Citation>Park S. Y. et al.. Schizandrin C exerts anti-neuroinflammatory effects by upregulating phase II detoxifying/antioxidant enzymes in microglia. International immunopharmacology 17, 415&#x2013;426, doi: 10.1016/j.intimp.2013.06.032 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2013.06.032</ArticleId><ArticleId IdType="pubmed">23859871</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo L. Y. et al.. Anti-inflammatory effects of schisandrin isolated from the fruit of Schisandra chinensis Baill. European journal of pharmacology 591, 293&#x2013;299, doi: 10.1016/j.ejphar.2008.06.074 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2008.06.074</ArticleId><ArticleId IdType="pubmed">18625216</ArticleId></ArticleIdList></Reference><Reference><Citation>Panossian A. &amp; Wikman G. Pharmacology of Schisandra chinensis Bail.: an overview of Russian research and uses in medicine. Journal of ethnopharmacology 118, 183&#x2013;212, doi: 10.1016/j.jep.2008.04.020 (2008).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jep.2008.04.020</ArticleId><ArticleId IdType="pubmed">18515024</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan G. et al.. Simultaneous and rapid determination of main lignans in different parts of Schisandra sphenanthera by micellar electrokinetic capillary chromatography. Molecules 16, 3713&#x2013;3722, doi: 10.3390/molecules16053713 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules16053713</ArticleId><ArticleId IdType="pmc">PMC6263323</ArticleId><ArticleId IdType="pubmed">21540798</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim H., Ahn Y. T., Kim Y. S., Cho S. I. &amp; An W. G. Antiasthmatic effects of schizandrae fructus extract in mice with asthma. Pharmacognosy magazine 10, S80&#x2013;85, doi: 10.4103/0973-1296.127348 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0973-1296.127348</ArticleId><ArticleId IdType="pmc">PMC4047578</ArticleId><ArticleId IdType="pubmed">24914313</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J. et al.. Effect of Schisandra chinensis on interleukins, glucose metabolism, and pituitary-adrenal and gonadal axis in rats under strenuous swimming exercise. Chinese journal of integrative medicine 21, 43&#x2013;48, doi: 10.1007/s11655-014-1765-y (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11655-014-1765-y</ArticleId><ArticleId IdType="pubmed">25141817</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu D. et al.. Deoxyschizandrin isolated from the fruits of Schisandra chinensis ameliorates Abeta(1)(-)(4)(2)-induced memory impairment in mice. Planta medica 78, 1332&#x2013;1336, doi: 10.1055/s-0032-1315019 (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-0032-1315019</ArticleId><ArticleId IdType="pubmed">22773410</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L. et al.. From the traditional Chinese medicine plant Schisandra chinensis new scaffolds effective on HIV-1 reverse transcriptase resistant to non-nucleoside inhibitors. Journal of microbiology 53, 288&#x2013;293, doi: 10.1007/s12275-015-4652-0 (2015).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12275-015-4652-0</ArticleId><ArticleId IdType="pubmed">25740376</ArticleId></ArticleIdList></Reference><Reference><Citation>Diamond M. S. et al.. Modulation of Dengue virus infection in human cells by alpha, beta, and gamma interferons. Journal of virology 74, 4957&#x2013;4966 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC110847</ArticleId><ArticleId IdType="pubmed">10799569</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H. W. et al.. The roles of IRF-3 and IRF-7 in innate antiviral immunity against dengue virus. Journal of immunology 191, 4194&#x2013;4201, doi: 10.4049/jimmunol.1300799 (2013).</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1300799</ArticleId><ArticleId IdType="pmc">PMC3795795</ArticleId><ArticleId IdType="pubmed">24043884</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasirudeen A. M. et al.. RIG-I, MDA5 and TLR3 synergistically play an important role in restriction of dengue virus infection. PLoS neglected tropical diseases 5, e926, doi: 10.1371/journal.pntd.0000926 (2011).</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0000926</ArticleId><ArticleId IdType="pmc">PMC3014945</ArticleId><ArticleId IdType="pubmed">21245912</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S. et al.. The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 18, 5727&#x2013;5737, doi: 10.1038/sj.onc.1202960 (1999).</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.onc.1202960</ArticleId><ArticleId IdType="pubmed">10523853</ArticleId></ArticleIdList></Reference><Reference><Citation>Parisien J. P. et al.. The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. Virology 283, 230&#x2013;239, doi: 10.1006/viro.2001.0856 (2001).</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/viro.2001.0856</ArticleId><ArticleId IdType="pubmed">11336548</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie J. M., Khromykh A. A. &amp; Parton R. G. Cholesterol manipulation by West Nile virus perturbs the cellular immune response. Cell host &amp; microbe 2, 229&#x2013;239, doi: 10.1016/j.chom.2007.09.003 (2007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2007.09.003</ArticleId><ArticleId IdType="pubmed">18005741</ArticleId></ArticleIdList></Reference><Reference><Citation>Melhem A. et al.. Treatment of chronic hepatitis C virus infection via antioxidants: results of a phase I clinical trial. Journal of clinical gastroenterology 39, 737&#x2013;742 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16082287</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu Y. C. et al.. Identification of a small-molecule inhibitor of dengue virus using a replicon system. Archives of virology 157, 681&#x2013;688, doi: 10.1007/s00705-012-1224-z (2012).</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-012-1224-z</ArticleId><ArticleId IdType="pubmed">22249364</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J. C. et al.. Andrographolide exerts anti-hepatitis C virus activity by up-regulating haeme oxygenase-1 via the p38 MAPK/Nrf2 pathway in human hepatoma cells. British journal of pharmacology 171, 237&#x2013;252, doi: 10.1111/bph.12440 (2014).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.12440</ArticleId><ArticleId IdType="pmc">PMC3874710</ArticleId><ArticleId IdType="pubmed">24117426</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>